FDA Targets 15 Companies Over Bogus Diabetes Treatments
The U.S. Food and Drug Administration on Tuesday warned 15 companies that their diabetes treatments were unapproved or otherwise violated federal law, saying it was seeking to remove the products from...To view the full article, register now.
Already a subscriber? Click here to view full article